Furthermore, as studies have shown that AMPK exerts opposite effects on the central nervous system and peripheral metabolism, activation of the system is not the best strategy to treat obesity, so site-specific operations on AMPK are necessary. Here, PRKAB1 is linked to obesity due to melanocortin 4 receptor deficiency.